Recursion Pharmaceuticals Correlations

RXRX Stock

USD 9.00 0.28 3.02%

The current 90-days correlation between Recursion Pharmaceuticals and Relay Therapeutics is -0.03 (i.e., Good diversification). The correlation of Recursion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Recursion Pharmaceuticals Correlation With Market

Good diversification

The correlation between Recursion Pharmaceuticals and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Recursion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Recursion Stock please use our How to Invest in Recursion Pharmaceuticals guide.

Moving together with Recursion Stock

0.73

PHGE

Biomx Inc

Pair Corr

Moving against Recursion Stock

0.69	ILMN	Illumina	Pair Corr
0.55	ABOS	Acumen Pharmaceuticals	Pair Corr
0.45	INZY	Inozyme Pharma	Pair Corr
0.39	NAMSW	NewAmsterdam Pharma	Pair Corr
0.35	KURA	Kura Oncology	Pair Corr
0.49	TCRX	Tscan Therapeutics	Pair Corr
0.48	CRNX	Crinetics Pharmaceuticals Earnings Call Today	Pair Corr
0.45	ADTX	Aditxt Inc	Pair Corr
0.43	TERN	Terns Pharmaceuticals	Pair Corr
0.42	DAWN	Day One Biopharmaceu	Pair Corr
0.39	STRO	Sutro Biopharma	Pair Corr
0.31	EMBC	Embecta Corp	Pair Corr
0.6	ADUS	Addus HomeCare	Pair Corr
0.49	TLKMF	Telkom Indonesia Tbk	Pair Corr
0.46	PTAIY	Astra International Tbk Earnings Call Today	Pair Corr
0.33	PTITF	PT Indosat Tbk	Pair Corr

Related Correlations Analysis

	ABSI	AFMD	SANA	RLAY	IMMX	CNSP	HEPA	FRLN	AVRO	EFTR
ABSI		-0.45	0.36	-0.38	-0.15	-0.35	-0.76	0.0	0.0	0.0	ABSI
AFMD	-0.45		-0.29	0.5	-0.15	0.35	0.77	0.0	0.0	0.0	AFMD
SANA	0.36	-0.29		0.06	-0.26	-0.22	-0.47	0.0	0.0	0.0	SANA
RLAY	-0.38	0.5	0.06		0.0	0.29	0.46	0.0	0.0	0.0	RLAY
IMMX	-0.15	-0.15	-0.26	0.0		0.16	0.21	0.0	0.0	0.0	IMMX
CNSP	-0.35	0.35	-0.22	0.29	0.16		0.51	0.0	0.0	0.0	CNSP
HEPA	-0.76	0.77	-0.47	0.46	0.21	0.51		0.0	0.0	0.0	HEPA
FRLN	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	FRLN
AVRO	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	AVRO
EFTR	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		EFTR
	ABSI	AFMD	SANA	RLAY	IMMX	CNSP	HEPA	FRLN	AVRO	EFTR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HEPA	+ 0.77	AFMD
HEPA	+ 0.51	CNSP
RLAY	+ 0.5	AFMD
HEPA	+ 0.46	RLAY
SANA	+ 0.36	ABSI
CNSP	+ 0.35	AFMD

High negative correlations

HEPA	- 0.76	ABSI
HEPA	- 0.47	SANA
AFMD	- 0.45	ABSI
RLAY	- 0.38	ABSI
CNSP	- 0.35	ABSI
SANA	- 0.29	AFMD

Risk-Adjusted Indicators

There is a big difference between Recursion Stock performing well and Recursion Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Recursion Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ABSI	5.96	0.85	0.14	0.29	5.79	(6.96)	17.57	(10.07)	41.22
AFMD	3.60	(1.57)	0.00	(1.00)	0.00	0.00	6.00	(9.85)	43.61
SANA	8.05	1.35	0.19	0.49	6.39	(11.15)	12.46	(11.88)	176.41
RLAY	3.71	(0.33)	0.00	(0.31)	0.00	0.00	7.42	(7.02)	24.83
IMMX	4.02	0.27	0.05	(0.74)	4.47	(5.01)	9.09	(7.69)	33.17
CNSP	5.08	(1.03)	0.00	2.62	0.00	0.00	8.74	(10.84)	70.89
HEPA	7.54	(1.27)	0.00	0.56	0.00	0.00	17.65	(11.11)	86.86
FRLN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AVRO	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EFTR	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Recursion Pharmaceuticals Corporate Management

Christopher Gibson	CEO CoFounder	Profile
Kevin Leggat	Vice Accounting	Profile
Janelle Gordon	Vice Operations	Profile
Shafique MD	Interim Officer	Profile
Nathan Hatfield	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC